Article
Lack of mutations in the TP53 tumor suppressor gene exons 5 to 8 in Fanconi's anemia.
Nouvelle revue francaise d'hematologie - 1 Jan 1991
Jonveaux P, Le Coniat M, Grausz D, Berger R
Abstract excerpt
The TP53 gene is considered to be a negative regulator of cell growth whose inactivation is an important step in the development or progression of malignancies. Recently, germ line TP53 mutations have been detected in a familial cancer syndrome, the dominantly inherited Li-Fraumeni syndrome. Using single strand conformation polymorphism analysis of PCR products, we looked for TP53 mutations in DNA of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
